Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1287-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 276, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
LEPREL2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr12:6839349-6839372 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MLEC hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.663
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:120698971-120698998 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MCM3 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:52282820-52282846 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GMNN hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:24781512-24781539 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PDE8B hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:77410723-77410743 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CSNK1A1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr5:149550296-149550321 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BBX hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.721
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:107808169-107808190 PAR-CLIP POSITIVE DIRECT TarBase 7.0
GORASP1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr3:39103528-39103549 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NCL hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr2:231461634-231461658 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NRBP1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:27435174-27435201 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RTN4 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:54972565-54972587 PAR-CLIP POSITIVE DIRECT TarBase 7.0
STRN hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.471
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr2:36843744-36843765 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RPL22 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.490
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:6185981-6186006 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SFPQ hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:35184513-35184538 HITS-CLIP POSITIVE DIRECT TarBase 7.0
IPO13 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.487
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:43961233-43961260 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CTNNAL1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:108942834-108942859 PAR-CLIP POSITIVE DIRECT TarBase 7.0
LPGAT1 hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.608
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:211747729-211747754 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AGO2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr8:140572906-140572933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CENPB hsa-miR-1287-5p low: 0 high: 1 1 1 1 0.494
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr20:3784245-3784266 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBA2 hsa-miR-1287-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:34470211-34470232 HITS-CLIP POSITIVE DIRECT TarBase 7.0